Reflux Esophagitis Phase III Study (Maintenance Treatment)

Status Completed

Clinical Trial Summary

The primary objective of this study is to evaluate the efficacy of esomeprazole 20 mg once daily for 24 weeks on maintenance of Reflux Esophagitis in patients with healed reflux esophagitis in comparison with omeprazole 10 mg once daily and esomeprazole 10 mg once daily by assessment of presence/absence of recurrence of Reflux Esophagitis throughout the treatment period (from the randomisation to the treatment completion) according to the Los Angeles classification.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00634114
Study type	Interventional
Source	AstraZeneca
Contact
Status	Completed
Phase	Phase 3
Start date	January 2008
Completion date	May 2009

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06170060` - Treatment of Reflux With Sleeve Gastrectomy	N/A
Not yet recruiting	`NCT06062225` - Protocol for Comparing the Efficacy of Three Reconstruction Methods of the Digestive Tract After Proximal Gastrectomy	N/A
Completed	`NCT01964131` - BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects	Phase 1
Not yet recruiting	`NCT06056973` - Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis	Phase 4
Completed	`NCT01008696` - An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis	Phase 4
Recruiting	`NCT05899491` - Role of ARMA in Selective Subset of Refractory GERD Patients.	N/A
Recruiting	`NCT01311908` - Incidence of Reflux Esophagitis After Pancreaticoduodenectomy	N/A
Completed	`NCT03214081` - Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"
Not yet recruiting	`NCT01560598` - Adipokines and the Risk of Reflux Esophagitis	N/A
Completed	`NCT00859287` - Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis	N/A
Completed	`NCT00206180` - NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis	Phase 4
Recruiting	`NCT04657848` - Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal Gastrectomy	N/A
Completed	`NCT02477475` - Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes	N/A
Completed	`NCT03553563` - A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer	Phase 3
Completed	`NCT01381991` - The Efficacy of i-Scan for Detecting Reflux Esophagitis	N/A
Completed	`NCT04673643` - Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Reflux Esophagitis	N/A
Recruiting	`NCT04531475` - Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis	Phase 2
Completed	`NCT00586963` - Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis	N/A
Completed	`NCT03388047` - Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett's Oesophagus	N/A
Recruiting	`NCT00155805` - Immunologic Factors in Reflux Esophagitis and Barrett’s Esophagus	N/A